Dr. John Holaday is formerly the Managing Director and CEO of QRxPharma Ltd (QRX, ASX), a specialty pharmaceutical company headquartered in Sydney, Australia. He served as co-founder of EntreMed, Inc. (ENMD, NASDAQ) in 1992, and co-founder of Medicis Pharmaceutical Corp. (MRX, NYSE) in 1988. He also co-founded MaxCyte, Inc. and is a member of the Board of Directors of Plasmonix (Chair), Pixspan, CytImmune Sciences and Accelovance.
He has raised over $500MM in private and public rounds of financing for these companies that have a collective market capitalization (or were acquired) in excess of $2 billion. Dr. Holaday served as a Captain in the US Army, and was at the Walter Reed Army Institute of Research as an officer and civilian for 21 years. Dr. Holaday obtained his BS (1966) and MS (1968) from the University of Alabama (UofA), and his PhD from the University of California San Francisco School of Medicine in 1976. He was named to the Ernst&Young’s Entrepreneur of the Year 2006 Hall of Fame, holds over 80 patents and published over 230 scientific articles, book chapters and four books.